Increased nm23 immunoreactivity is associated with selective inhibition of systemic tumour cell dissemination

Journal of Clinical Pathology

Volumn 55, Issue 3, 2002, Pages 184-190

  Graham, Alastair N J ^a   Maxwell, P ^a   Mulholland, K ^a   Patterson, A H ^a   Anderson, N ^a   McManus, K G ^a   Bharucha, H ^b   McGuigan, J A ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL MARKER; EPITHELIAL MEMBRANE ANTIGEN; GENE PRODUCT; PROTEIN NM23; UNCLASSIFIED DRUG;

AGED; ARTICLE; BONE MARROW METASTASIS; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; METASTASIS INHIBITION; MICROVASCULATURE; MORPHOLOGY; PLEURA METASTASIS; PRIORITY JOURNAL;

EID: 0036204891     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.3.184     Document Type: Article

References (35)

1. Somatic allelic deletion of nm23 in human cancer
2. Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions
3. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme
4. Evidence for a novel gene associated with low tumor metastatic potential
5. Reduced Nm23/Awd protein in tumour metastasis and aberrant drosophila development
6. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells
7. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization ond enzymatic activity
8. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells
9. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential
10. Expression of the antimetastatic gene nm23 in human breast cancer: On association with good prognosis
11. Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression
12. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas
13. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages
14. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: A useful marker in prediction of metastases
15. Expression of nm23 protein in pulmonary adenocarcinomas: Inverse correlation to tumor progression
16. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage 1 non-small cell lung cancer
17. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value
18. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma
19. Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas
20. Immunohistochemical analysis of nm23-HI gene product in node-positive lung cancer and lymph nodes
21. Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: Association with tumor progression in Clara cell type
22. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: Association with tumor progression in squamous carcinoma
23. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
24. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
25. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
26. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer
27. Tumor angiogenesis in human lung adenocarcinoma
28. NM23 gene expression correlates with cell growth rate and S-phase
29. The relationship between nm23, ongiogenesis, and the metastatic proclivity of node-negative breast cancer
30. Separating favorable from unfavorable prognostic markers in breast cancer: The role of E-cadherin
31. Relation of neovascularisation to metastasis of non-small-cell lung cancer
32. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Fl1) and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival
33. Immunocytochemical markers in stage 1 lung cancer: Relevance to prognosis
34. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity
35. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer